Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31323936 | 1.00 | CHRM2 (0.39) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL18669067 | 0.89 | ALDH1A1 (0.42) | ALDH1A1FKBP1AEPHX1 | |
| SCHEMBL31323801 | 0.89 | CHRM2 (0.36) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL31323881 | 0.89 | CHRM2 (0.36) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL18668859 | 0.87 | ALDH1A1 (0.40) | ALDH1A1FKBP1AEPHX1ACHE | |
| SCHEMBL31323824 | 0.86 | CHRM2 (0.35) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL28099782 | 0.83 | ALDH1A1 (0.46) | ALDH1A1FKBP1AEPHX1 | |
| SCHEMBL31323898 | 0.82 | ALDH1A1 (0.37) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL13291850 | 0.82 | ALDH1A1 (0.47) | ALDH1A1FKBP1AEPHX1 | |
| SCHEMBL31323831 | 0.82 | CHRM2 (0.33) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025035202-A1 | IONIZABLE LIPIDS COMPRISING MACROCYCLIC RINGS FOR THE DELIVERY OF THERAPEUTIC AGENTS | NANOVATION THERAPEUTICS INC. (CA) | 2025-02-20 | — | — | WO | disclosed |